CompoundingGain

First Oral approved favipiravir medication for COVID

ロング
NSE:GLENMARK   GLENMARK PHARM


Sitting just under resistance at 421 expect this to be taken out on open and the retest IF it happens is a good spot to load up.

Recon this should fly to 574 then get knocked back a bit for a while before flying up with more power .

Might be wrong and the FOMO on this may keep blasting it up , the downtrend line is not that far off so all indicators should turn into buy once that is taken out .

Lets see ..

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。